4//SEC Filing
Bazley Mathew C. 4
Accession 0001209191-18-054155
CIK 0001636050other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 8:18 PM ET
Size
8.8 KB
Accession
0001209191-18-054155
Insider Transaction Report
Form 4
Bazley Mathew C.
General Counsel
Transactions
- Award
Stock Option ( Right to Buy)
2018-10-01+250,000→ 250,000 totalExercise: $2.28Exp: 2028-09-30→ Common Stock (250,000 underlying) - Award
Stock Option ( Right to Buy)
2018-10-01+200,000→ 200,000 totalExercise: $2.28Exp: 2028-09-30→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on October 1, 2019 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date.
- [F2]The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.
- [F3]One-third of the option will vest at such time as the Issuer's stock price is equal to or greater than $6.84 per share; one-third of the option will vest at such time as the Issuer's stock price is equal to or greater than $11.40 per share; and one-third of the option will vest at such time as the Issuer's stock price is equal to or greater than $15.96 per share, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date.
Documents
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001755060
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 8:18 PM ET
- Size
- 8.8 KB